[{"NetIncomeLoss_2_Q2_USD":-54411000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":14765000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7226000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":34041000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":34053000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":10167000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":133000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":12969000.0,"IncomeTaxesPaid_2_Q2_USD":45000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q2_USD":0.0,"RevenueFromRelatedParties_1_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":64585000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.92,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1133000.0,"AssetsCurrent_0_Q2_USD":131311000.0,"OtherNoncashIncomeExpense_2_Q2_USD":4000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":30752000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7193000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7424000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":61000.0,"CommonStockSharesIssued_0_Q2_shares":34065000.0,"Assets_0_Q2_USD":158901000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":7.89,"Depreciation_2_Q2_USD":1795000.0,"RevenueFromRelatedParties_2_Q2_USD":0.0,"Liabilities_0_Q2_USD":31632000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":15296000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":128000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":40669000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21023000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":8.41,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":95387000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-11000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":79000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":4124000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1035000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":285000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":12000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4000.0,"CommonStockValue_0_Q2_USD":34000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":92000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1613000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q2_USD":3100000.0,"RestrictedCash_0_Q2_USD":1270000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-54332000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-27979000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":741000.0,"OtherAssetsNoncurrent_0_Q2_USD":2428000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":74463000.0,"ShareBasedCompensation_2_Q2_USD":5261000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":16264000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-61000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6751000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-161570000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":21222000.0,"CommonStockSharesOutstanding_0_Q2_shares":34065000.0,"RestrictedCashNoncurrent_0_Q2_USD":1300000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2643000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-44976000.0,"LiabilitiesCurrent_0_Q2_USD":16336000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":10253000.0,"AccountsPayableCurrent_0_Q2_USD":3034000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":95000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":75733000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":99000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":206000.0,"AdditionalPaidInCapital_0_Q2_USD":288672000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":16000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":25000.0,"OperatingLeasePayments_2_Q2_USD":2190000.0,"IncomeLossAttributableToParent_2_Q2_USD":-54399000.0,"IncomeLossAttributableToParent_1_Q2_USD":-27964000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8898000.0,"NetIncomeLoss_1_Q2_USD":-27968000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4106000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":50000.0,"StockholdersEquity_0_Q2_USD":127269000.0,"OtherLiabilitiesCurrent_0_Q2_USD":53000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":1514000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":4.22,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":4.15,"CommonStockSharesAuthorized_0_Q2_shares":160000000.0,"OperatingIncomeLoss_2_Q2_USD":-55434000.0,"OperatingIncomeLoss_1_Q2_USD":-28249000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":52742000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":100000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.65,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.01,"LiabilitiesAndStockholdersEquity_0_Q2_USD":158901000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4055000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5261000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2643000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":13400000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3082000.0,"OperatingExpenses_2_Q2_USD":55434000.0,"OperatingExpenses_1_Q2_USD":28249000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":1181000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.6,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.82,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":8707000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":5906000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]